Bedside neuropathy disability score compared to quantitative sensory testing for measurement of diabetic neuropathy in children, adolescents, and young adults with type 1 diabetes

Journal of Diabetes and its Complications

Volumn 21, Issue 1, 2007, Pages 13-19

  Weintrob, Naomi ^a,b   Amitay, Iris ^a   Lilos, Pearl ^a   Shalitin, Shlomit ^a,b   Lazar, Liora ^a   Josefsberg, Zeev ^a,b  

^a SCHNEIDER CHILDREN S MEDICAL CENTER OF ISRAEL   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

Author keywords

Diabetic peripheral neuropathy; HbA1c; Neuropathy disability score; quantitative sensory testing

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C;

ADOLESCENT; ADULT; ARTICLE; BEDSIDE NEUROPATHY DISABILITY SCORE; CHILD; COLD SENSATION; CONTROLLED STUDY; CORRELATION ANALYSIS; COST BENEFIT ANALYSIS; DIABETIC NEUROPATHY; DISEASE DURATION; EVALUATION; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; NEUROPATHY; PERIPHERAL NEUROPATHY; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; QUANTITATIVE SENSORY TESTING; SCORING SYSTEM; SENSORY ANALYSIS; VIBRATION;

ADOLESCENT; ADULT; CHILD; DIABETES MELLITUS, TYPE 1; DIABETIC NEPHROPATHIES; DISABILITY EVALUATION; DISABLED PERSONS; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; ISRAEL; MALE; POINT-OF-CARE SYSTEMS; REPRODUCIBILITY OF RESULTS; SENSORY THRESHOLDS; VIBRATION;

EID: 33845784226     PISSN: 10568727     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jdiacomp.2005.11.002     Document Type: Article

References (26)

1. Abbott C.A., Carrington A.L., Ashe H., Bath S., Every L.C., Griffiths J., Hann A.W., Hussein A., Jackson N., Johnson K.E., Ryder C.H., Torkington R., Van Ross E.R., Whalley A.M., Widdows P., Williamson S., Boulton A.J., and North-West Diabetes Foot Care Study. North-West Diabetes Foot Care Study: Incidence of, and risk factors for, new diabetic foot ulceration in a community-based patient cohort. Diabetic Medicine 19 (2002) 377-384
2. Arezzo J.C. Quantitative sensory testing. In: Gries F.A., Cameron N.E., Low P.A., and Ziegler D. (Eds). Textbook of diabetic neuropathy (2003), Thieme, Stuttgart 184-189
3. Assal J.P., Muhlhauser I., Pernet A., Gfeller R., Jorgens V., and Berger M. Patient education as the basis for diabetes care in clinical practice and research. Diabetologia 28 (1985) 660-663
4. Boulton A.J. Why bother educating the multidisciplinary team and the patient? The example of prevention of lower extremity amputation in diabetes. Patient Education and Counseling 26 (1995) 183-188
5. Boulton A.J.M., Malik R.A., Arezzo J.C., and Sosenko J.M. Diabetic somatic neuropathies. Diabetes Care 27 (2004) 1458-1486
6. Brown M.J., Bird S.J., Watling S., Kaleta H., Hayes L., Eckert S., Foyt H.L., and Zenarest study. Natural progression of diabetic peripheral neuropathy in the Zenarestat study population. Diabetes Care 27 (2004) 1153-1159
7. DCCT Research Group. The effect of intensive diabetes therapy on the development and progression of neuropathy. Annals of Internal Medicine 122 (1995) 561-568
8. In: Dixon W.J. (Ed). BMDP statistical software (1993), University of California Press, Los Angeles
9. Dyck P.J. Detection, characterization and staging of polyneuropathy assessed in diabetics. Muscle & Nerve 11 (1988) 21-32
10. Dyck P.J., Davies J.L., Wilson D.M., Service F.J., Melton L.J., and O'Brien P.C. Risk factors for severity of diabetic polyneuropathy. Diabetes Care 22 (1999) 1479-1486
11. Dyck P.J., Melton L.J., O'Brien P.C., and Service F.J. Approaches to improve epidemiological studies of diabetes neuropathy. Insight from the Rochester Diabetic Neuropathy Study. Diabetes 46 Suppl 2 (1997) S5-S8
12. Guy R.J.C., Clark C.A., Malcolm P.N., and Watkins P.J. Evaluation of thermal and vibration sensation in diabetic neuropathy. Diabetologia 28 (1985) 131-137
13. Hotta N., Toyota T., Matsuoka K., Shigeta Y., Kikkawa R., Kaneko T., Takahashi A., Sugimura K., Koike Y., Ishii J., Sakamoto N., and SNK-860 Diabetic Neuropathy Study Group. Clinical efficacy of fidarestat, a novel aldose reductase inhibitor, for diabetic peripheral neuropathy. Diabetes Care 24 (2001) 1776-1782
14. Maser R.E., Nielsen V.K., Bass E.B., Manjoo Q., Dorman J.S., Kelsey S.F., Becker D.J., and Orchard T.J. Measuring diabetic neuropathy. Assessment and comparison of clinical examination and quantitative sensory testing. Diabetes Care 12 (1989) 270-275
15. Masson E.A., Veves A., Fernando D., and Boulton A.J. Current perception thresholds: A new, quick and reproducible method for the assessment of peripheral neuropathy in diabetes mellitus. Diabetologia 32 (1989) 724-728
16. Mayfield J.A., Reiber G.E., Sanders L.J., Janisse D., and Pogach L.M. Preventive foot care in people with diabetes. Diabetes Care 21 12 (1998) 2161-2177
17. Olsen B.S., Nir M., Kjaer I., Volund A., and Mortensen S.B. Elevated vibration perception threshold in young patients with type 1 diabetes in comparison to non-diabetic children and adolescents. Diabetic Medicine 11 (1994) 888-892
18. Proceedings of a consensus development conference on standardized measures in diabetic neuropathy. Neurology 42 (1992) 1823-1839
19. Shalitin S., Lilus P., De Vries L., Josefsberg Z., Phillip M., and Weintrob N. Bedside scoring procedure for the diagnosis of diabetic peripheral neuropathy in patients with type 1 diabetes. Journal of Pediatric Endocrinology & Metabolism 15 (2002) 613-620
20. Shy M.E., Frohman E.M., So Y.T., Arezzo J.C., Cornblath D.R., Giuliani M.J., Kincaid J.C., Ochoa J.L., Parry G.J., Weimer L.H., and Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Quantitative sensory testing. Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology 60 (2003) 898-904
21. Vinik A.I., and Mehrabyan A. Diabetic neuropathies. Medical Clinics of North America 88 (2004) 947-999
22. Watkins P.J. Natural history of diabetic neuropathies. Quarterly Journal of Medicine, New Series 77 (1990) 1209-1218
23. Yarnitsky D. Quantitative sensory testing (QST). Muscle & Nerve 20 (1997) 196-204
24. Yarnitsky D., and Sprecher E. Thermal testing: Normative data and repeatability for various test algorithms. Journal of Neurological Sciences 125 (1994) 39-45
25. Young M.J., Boulton A.J., Macleod A.F., Williams D.R., and Sonksen P.H. A multicenter study of the prevalence of diabetic peripheral neuropathy in the United Kingdom hospital clinic population. Diabetologia 36 (1993) 150-154
26. Ziegler D., Hanefeld M., Ruhnau K.J., Hasche H., Lobisch M., Schutte K., Kerum G., and Malessa R. Treatment of symptomatic diabetic polyneuropathy with the antioxidant alpha-lipoic acid: A 7-month multicenter randomized controlled trial (ALADIN III Study). ALADIN III Study Group. Alpha-lipoic acid in diabetic neuropathy. Diabetes Care 22 (1999) 1296-1301